Billionaire T. Boone Pickens’ Latest Stock Picks Include Halliburton

T Boone PickensT. Boone Pickens became a billionaire through his operations in oil, and now manages a fund which primarily invests in energy. The long stock picks of BP Capital are reported in 13F filings six to seven weeks after the end of each quarter, and recently it filed the 13F for the third quarter of 2012. We have been going through these documents at various funds and picking out specific stocks and broader investment decisions that we think investors might fund interesting. Read on for our evaluation of some of Pickens’s investment themes and compare his activity to previous filings.

Halliburton. Pickens hadn’t owned any shares of Halliburton Company (NYSE:HAL) at the end of June, but had initiated a position of about 150,000 shares by the end of the third quarter. The equipment and services company looks cheap to us at 10 times earnings (on either a trailing or a forward basis) with the sell-side expecting enough growth over the next several years to generate a five-year PEG ratio of 0.6. The business has been struggling a bit, but when we had looked at its larger peer Schlumberger we had come to the conclusion that Halliburton was a better value play. Read more about why we think that Halliburton is a better buy than Schlumberger.

Valero. For the third quarter in a row, Pickens increased his stake in Valero Energy Corporation (NYSE:VLO) and it is now the largest position in his 13F portfolio. Valero is a refining and marketing company- little drilling exposure here- which produces gasoline, ethanol, and other fuels and compounds. At a market capitalization of over $16 billion, it trades at 15 times trailing earnings but Wall Street analysts expect strong growth in 2013 and so the forward P/E is only 6. Fellow billionaire Israel Englander’s Millennium Management had owned the stock during the second quarter of the year. However, earnings have been slipping and the company is therefore dependent on seeing a strong reversal in its business prospects.

Less drilling. Pickens cut his stake in Transocean LTD (NYSE:RIG), an offshore contract driller, in half; he also sold about half his shares of independent integrated oil company Mcmoran Exploration Co (NYSE:MMR); he sold out of oil major EnCana Corporation (NYSE:ECA), which had been one of his top ten holdings. It’s possible that he decided against these names in particular, but coupled with the addition to Valero our interpretation is that Pickens and his team are trying to move their dollars further downstream. Transocean actually seems to be in a decent place- its revenue was up in the third quarter from a year earlier, and the forward P/E of 9 suggests that analysts consider it a good value- so perhaps investors should be looking at that as a potential long. We’re more sour on the other two oil companies: sales at each were down over 30% during the same time frame. McMoRan is widely shorted, with 22% of the outstanding shares held short as of the most recent data, and traders might look to join that side of the market as the sell-side doesn’t expect it to be profitable this year or next year. Encana also looks high priced, at 28 times consensus earnings for 2013, though it has a high dividend yield. We think that we’d avoid it.

We’d note that supermajors Exxon Mobil, BP, and Chevron are absent from Pickens’ 13F entirely; it’s possible that this ties in to a negative attitude towards drilling. We’ve mentioned that we think that investors should be taking a look at Halliburton if they want to buy a good long-term energy stock. Valero would require considerably more review; certainly if it hits analyst targets it will prove undervalued at the current price, but that would require much better performance than what the company has done recently.

Biotech Insider Alert - $6 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.
Click here to Read Comments
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 74 percentage points in 2.5 years. Our beta is only 1.2 (download a FREE newsletter and see the details inside)

Lists

Best Selling Magazines in the World

Shortest People in History

The Most Celebrated Holidays in the World

Most Expensive Handbag Brands in the World

Top Selling Comic Book Issues of this Century

The Most Powerful Women in Politics

Best Paid DJs

Most Rebellious Female Artists

Best Paid TV Actresses of 2014

Best Paid Actors of 2014

Most Expensive Horses in the World

Tallest People Ever

Most Encouraging Feminist Celebrities

Best Paid Supermodels of 2014

Top 10 Suburbs for Retirement in 2015

10 Wealthiest Cities in America

Top 10 TED Talks for Entrepreneurs

Best TED Talks on Education

25 Most Dangerous Places to Live in America

Top 10 Ski Resorts in the United States – 2014 List

Top 10 Most Remote Places in the World

Most Visited Museums in the United States

Wealthiest Photographers in the World

Most Famous Gay Athletes

The World’s Most Famous Circuses

Best Hair Stylists

Most Popular NASCAR Drivers

The Best Romance Movies of all Time

The Most Wanted Drug Lords

The Oldest Money Managers

The Greatest Directors in the World

Largest Animals in the World

World’s Most Expensive Desserts

Best Selling Comic Books of All Time

A-list Actors who Sabotaged Their Career

Rappers With a College Degree

The Best Jazz Albums of all Time

The Most Influential Jazz Musicians

The World’s Most Famous Photographers

The Best Oscar-Winning Songs

Most Influential Choreographers Ever

Most Expensive Department Stores in the World

The Most Expensive Stolen Paintings in the World

The World’s Most Expensive Teas

Top Oscar Record Holders

The Most Expensive Flowers in the World

Countries With a Booming Film Industry

Most Expensive Cupcakes in the World

Uncommon European Escapes

The Most Stolen Artists in History

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 129% in 2.5 years!! Wondering How?

Download a complete edition of our newsletter for free!